Clinical Trial Update: Post Market Surveillance for Infanrix™

View source ↗

Summary

Post-market surveillance study for Infanrix evaluated safety in diphtheria, acellular pertussis, and tetanus; results posted in 2009 after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Infanrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Acellular Pertussis | Status: COMPLETED | Results posted: 2009-07-17